DK294685A - Apparat og fremgangsmaade til pulseret administration af vaekstfremmende midler - Google Patents

Apparat og fremgangsmaade til pulseret administration af vaekstfremmende midler Download PDF

Info

Publication number
DK294685A
DK294685A DK294685A DK294685A DK294685A DK 294685 A DK294685 A DK 294685A DK 294685 A DK294685 A DK 294685A DK 294685 A DK294685 A DK 294685A DK 294685 A DK294685 A DK 294685A
Authority
DK
Denmark
Prior art keywords
procedure
growth promoting
promoting agents
pulsed administration
pulsed
Prior art date
Application number
DK294685A
Other languages
Danish (da)
English (en)
Other versions
DK294685D0 (da
Inventor
Daniel M Linkie
Michael O Thorner
Original Assignee
Daniel M Linkie
Michael O Thorner
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daniel M Linkie, Michael O Thorner filed Critical Daniel M Linkie
Publication of DK294685D0 publication Critical patent/DK294685D0/da
Publication of DK294685A publication Critical patent/DK294685A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Fodder In General (AREA)
DK294685A 1984-06-29 1985-06-28 Apparat og fremgangsmaade til pulseret administration af vaekstfremmende midler DK294685A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/626,400 US4747825A (en) 1984-06-29 1984-06-29 Apparatus and methodology for pulsed administration of growth promoting agents

Publications (2)

Publication Number Publication Date
DK294685D0 DK294685D0 (da) 1985-06-28
DK294685A true DK294685A (da) 1985-12-30

Family

ID=24510242

Family Applications (1)

Application Number Title Priority Date Filing Date
DK294685A DK294685A (da) 1984-06-29 1985-06-28 Apparat og fremgangsmaade til pulseret administration af vaekstfremmende midler

Country Status (16)

Country Link
US (1) US4747825A (fr)
EP (1) EP0190199A4 (fr)
JP (1) JPS61502519A (fr)
AU (1) AU4605385A (fr)
BE (1) BE902783A (fr)
BR (1) BR8506785A (fr)
DK (1) DK294685A (fr)
FI (1) FI852516L (fr)
IL (1) IL75671A0 (fr)
MW (1) MW686A1 (fr)
NO (1) NO852603L (fr)
OA (1) OA08214A (fr)
PT (1) PT80738B (fr)
RO (1) RO95012A (fr)
WO (1) WO1986000233A1 (fr)
ZA (1) ZA854916B (fr)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5089472A (en) * 1988-01-26 1992-02-18 Laboratorios Serono S.A. Use of growth hormone releasing factor for improving mental function
US5065748A (en) * 1989-11-14 1991-11-19 University Of South Florida Method of diagnosing growth hormone disorders employing somatostatin and growth hormone releasing hormone
US5065747A (en) * 1989-11-21 1991-11-19 University Of South Florida Method for improving the accuracy of diagnosis of growth hormone deficiency
US5428013A (en) * 1991-01-04 1995-06-27 Mugica; Jesus D. Differential diagnosis and treatment of the states of growth hormone insufficiency (or deficiency) with an alpha-2-adrenergic agonist and a growth hormone releasing peptide
US7910624B1 (en) 1995-03-03 2011-03-22 The Trustees Of Boston University Compositions for the treatment of blood disorders
AU696167B2 (en) * 1993-10-29 1998-09-03 Trustees Of Boston University Physiologically stable compositions of butyric acid, and butyric acid salts and derivatives as anti-neoplastic agents
JPH10511095A (ja) * 1994-12-19 1998-10-27 ベス イスラエル ディーコネス メディカル センター インコーポレイテッド 副甲状腺ホルモン又はその作動薬の低用量継続投与
WO1998004290A2 (fr) 1996-07-26 1998-02-05 Perrine Susan P Compositions contenant un agent inducteur ainsi qu'un agent antiviral et destinees au traitement de troubles cellulaires, sanguins et viraux
US6403647B1 (en) 1996-07-26 2002-06-11 Susan P. Perrine Pulsed administration of compositions for the treatment of blood disorders
US5939456A (en) * 1996-07-26 1999-08-17 Perrine; Susan P. Pulsed administration of compositions for the treatment of blood disorders
ES2146530B1 (es) * 1997-12-26 2001-04-16 Consejo Superior Investigacion Utilizacion del factor de crecimiento igf-i en la fabricacion de composiciones utiles en el tratamiento de la ataxia cerebelar.
AU774861B2 (en) * 1998-02-11 2004-07-08 Douglas V Faller Compositions and methods for the treatment of cystic fibrosis
ES2343518T3 (es) * 2002-09-09 2010-08-03 Hanall Biopharma Co., Ltd. Polipeptidos interferon alfa modificados resistentes a proteasas.
US7998930B2 (en) 2004-11-04 2011-08-16 Hanall Biopharma Co., Ltd. Modified growth hormones
WO2010105112A1 (fr) * 2009-03-11 2010-09-16 Hemaquest Pharmaceuticals, Inc. Détection d'acides gras à chaîne courte dans des échantillons biologiques
WO2011014775A1 (fr) 2009-07-31 2011-02-03 The Brigham And Women's Hospital, Inc. Modulation de l’expression de sgk1 dans les cellules th17 pour moduler les réponses immunitaires médiées par th17
US20110086869A1 (en) 2009-09-24 2011-04-14 The Trustees Of Boston University Methods for treating viral disorders
MA33899B1 (fr) 2009-12-08 2013-01-02 Hemaquest Pharmaceuticals Inc Procedes et regimes a faible dose pour des troubles des globules rouges
US20110245154A1 (en) 2010-03-11 2011-10-06 Hemaquest Pharmaceuticals, Inc. Methods and Compositions for Treating Viral or Virally-Induced Conditions
EP2670426B1 (fr) 2011-01-31 2017-05-10 The General Hospital Corporation Molécules trail multimodales et leurs utilisations en thérapies cellulaires
US9585930B2 (en) 2011-03-20 2017-03-07 Trustees Of Boston University Therapeutic agent for emphysema and COPD
WO2012151474A2 (fr) 2011-05-04 2012-11-08 Trustees Of Boston University Stimulation de la force proton motrice pour potentialiser des antibiotiques aminoglycosides contre bactéries persistantes
WO2013003697A1 (fr) 2011-06-30 2013-01-03 Trustees Of Boston University Méthode de régulation de croissance tumorale, d'angiogenèse et de métastase à l'aide du récepteur 1 riche en proline et contenant une immunoglobuline (igpr-1)
WO2013055985A1 (fr) 2011-10-12 2013-04-18 Children's Medical Center Corporation Compositions combinatoires et méthodes de traitement d'hémoglobinopathies
US9243037B2 (en) 2011-11-10 2016-01-26 Trustees Of Boston College Gramicidin a mutants that function as antibiotics with improved solubility and reduced toxicity
US9173884B2 (en) 2011-11-30 2015-11-03 Trustees Of Boston College Inhibitors of phosphodiesterase 11 (PDE11)
WO2014022332A1 (fr) 2012-07-31 2014-02-06 The Brigham And Women's Hospital, Inc. Modulation de la réponse immunitaire
EP2890720B1 (fr) 2012-08-30 2019-07-17 The General Hospital Corporation Compositions et méthodes de traitement du cancer
US20150273056A1 (en) 2012-10-12 2015-10-01 The Brigham And Women's Hospital, Inc. Enhancement of the immune response
US20150366890A1 (en) 2013-02-25 2015-12-24 Trustees Of Boston University Compositions and methods for treating fungal infections
EP3036226B1 (fr) 2013-08-22 2020-01-08 The General Hospital Corporation Inhibiteurs de la 12/15-lipoxygénase- humaine
EP3038625A4 (fr) 2013-08-29 2017-08-23 Trustees of Boston University Produits métaboliques intermédiaires pour potentialiser des antibiotiques aminoglycosides dans des infections bactériennes
EP3663763B1 (fr) 2013-11-26 2022-02-16 The Brigham and Women's Hospital, Inc. Compositions et procédés de modulation d'une réponse immunitaire
US11135269B2 (en) 2013-12-11 2021-10-05 The General Hospital Corporation Use of mullerian inhibiting substance (MIS) proteins for contraception and ovarian reserve preservation
WO2015143343A2 (fr) 2014-03-21 2015-09-24 The Brigham And Women's Hospital, Inc. Procédés et compositions pour le traitement de maladies immunitaires ou de troubles et/ou la surveillance thérapeutique
EP3134733B1 (fr) 2014-04-25 2020-10-14 The Brigham and Women's Hospital, Inc. Test et procédé pour traiter des patients ayant des maladies à médiation immunitaire
JP6792454B2 (ja) 2014-04-25 2020-11-25 ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッドＴｈｅ Ｂｒｉｇｈａｍ ａｎｄ Ｗｏｍｅｎ’ｓ Ｈｏｓｐｉｔａｌ， Ｉｎｃ． アルファ−フェトプロテイン（ａｆｐ）を操作するための方法
WO2016044707A1 (fr) 2014-09-18 2016-03-24 Cedars-Sinai Medical Center Compositions et procédés de traitement de la fibrose
GB2557389B (en) 2015-01-14 2020-12-23 Brigham & Womens Hospital Inc Treatment of cancer with anti-lap monoclonal antibodies
EP4194001A1 (fr) 2015-04-22 2023-06-14 Cedars-Sinai Medical Center Oligopeptides amers administrés par voie entérique pour le traitement du diabète de type 2 et de l'obésité
WO2016196664A1 (fr) 2015-06-01 2016-12-08 Cedars-Sinai Medical Center Procédés et utilisation de composés qui se lient à rela de nf-kb
CN116712552A (zh) 2015-06-19 2023-09-08 波士顿大学托管委员会 用于治疗疱疹病毒诱导的病况的方法和组合物
BR112018001441A2 (pt) 2015-07-28 2018-09-11 Vyome Biosciences Pvt Ltd antibacterianos terapêuticos e profiláticos
US10702586B2 (en) 2015-09-28 2020-07-07 Children's Hospital Los Angeles Methods for treating diseases mediated by ErbB4-positive pro-inflammatory macrophages
US20190255107A1 (en) 2015-10-09 2019-08-22 The Brigham And Women's Hospital, Inc. Modulation of novel immune checkpoint targets
WO2018013975A1 (fr) 2016-07-15 2018-01-18 Viracta Therapeutics, Inc. Inhibiteurs hdac destinés à être utilisés avec des thérapies à base de cellules nk.
WO2018067991A1 (fr) 2016-10-07 2018-04-12 The Brigham And Women's Hospital, Inc. Modulation de nouvelles cibles de points de contrôle immunitaires
EP3752532A1 (fr) 2018-02-12 2020-12-23 Diabetes-Free, Inc. Anticorps monoclonaux anti-cd40 humain antagonistes améliorés
WO2020102454A1 (fr) 2018-11-13 2020-05-22 Regents Of The University Of Minnesota Peptides ciblant le cd40 et leurs utilisations
CN114206447A (zh) 2019-05-31 2022-03-18 维拉克塔附属公司 用组蛋白脱乙酰基酶抑制剂治疗病毒相关的癌症的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3498228A (en) * 1967-05-01 1970-03-03 Charles A Blumle Portable infusion pump
US3559644A (en) * 1967-12-14 1971-02-02 Robert F Shaw Liquid infusion apparatus
US3809871A (en) * 1972-12-01 1974-05-07 Nasa Programmable physiological infusion
US4273122A (en) * 1976-11-12 1981-06-16 Whitney Douglass G Self contained powered injection system
US4313439A (en) * 1980-03-24 1982-02-02 Biotek, Inc. Automated, spring-powered medicament infusion system
DE3015777A1 (de) * 1980-04-24 1981-10-29 Ferring Arzneimittel Gmbh, 2300 Kiel Vorrichtung zur intermittierenden pulsatorischen applikation von fluessigen arzneimitteln
US4306553A (en) * 1980-07-22 1981-12-22 The Regents Of The University Of Minnesota Method of maintaining the fluidity of hormone solutions for parenteral administration
US4517181A (en) * 1982-09-15 1985-05-14 The Salk Institute For Biological Studies Mammalian PGRF
US4529595A (en) * 1983-01-13 1985-07-16 The Salk Institute For Biological Studies GRF Analogs

Also Published As

Publication number Publication date
JPS61502519A (ja) 1986-11-06
DK294685D0 (da) 1985-06-28
FI852516A0 (fi) 1985-06-26
RO95012A (fr) 1988-09-15
BE902783A (fr) 1985-10-16
EP0190199A1 (fr) 1986-08-13
OA08214A (en) 1987-10-30
PT80738B (en) 1986-12-11
ZA854916B (en) 1986-02-26
MW686A1 (en) 1987-03-11
US4747825A (en) 1988-05-31
EP0190199A4 (fr) 1987-12-01
FI852516L (fi) 1985-12-30
BR8506785A (pt) 1986-11-25
IL75671A0 (en) 1985-10-31
NO852603L (no) 1985-12-30
PT80738A (en) 1985-07-01
AU4605385A (en) 1986-01-24
WO1986000233A1 (fr) 1986-01-16

Similar Documents

Publication Publication Date Title
DK294685D0 (da) Apparat og fremgangsmaade til pulseret administration af vaekstfremmende midler
DK159129C (da) Apparat og fremgangsmaade til hoestning af afgroeder
DK245990A (da) Apparat og fremgangsmaade til fjernelse af legemsobstruktioner
DK166396C (da) Fremgangsmaade og apparat til akustisk undersoegelse af borehuller
DK63887D0 (da) Apparat og fremgangsmaade til sterilisering af beholdere
DK179187D0 (da) Apparat og fremgangsmaade til hoestning af afgroeder
DK378388A (da) Fremgangsmaade og apparat til fremstilling af pyramidestubformede daaseemner
DK237486A (da) Fremgangsmaade og apparat til udskaering af skind
DK149385D0 (da) Apparat og fremgangsmaade til fremstilling af ispinde
DK162030C (da) Fremgangsmaade og apparat til stoebning af langstrakte betonelementer
DK122586A (da) Apparat og fremgangmaade til fremstilling af is
DK356486D0 (da) Apparat og fremgangsmaade til vaadbehandling af tekstiler
DK606986D0 (da) Fremgangsmaade og apparat til vaekst af enkeltkrystallegemer
DK28290D0 (da) Fremgangmaade og apparat til rensning af affedtningsoploesninger
DK541986A (da) Apparat og fremgangsmaade til udsproejtning af kemikalier over afgroeder
DK242186D0 (da) Fremgangsmaade og apparat til fremstilling af taeppefliser
DK377286D0 (da) Apparat og fremgangsmaade til overfoering og behandling af afgroeder
NO156895C (no) Fremgangsmaate og apparat for dosering av pulverformige materialer.
DK276686A (da) Fremgangsmaade og apparat til behandling af sortlud
DK66687A (da) Fremgangsmaade og apparat til styring af krystallisationen af fedt
DK405488A (da) Netstroempepakning samt fremgangsmaade og apparat til fremstilling af netstroempepakning
DK95385D0 (da) Fremgangsmaade og apparat til behandling af krystalsukker
DK66287D0 (da) Fremgangsmaade og apparat til formning af beholdere
DK41784A (da) Fremgangsmaade og apparat til stabling af genstande

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment